{"data_non_statistical":false,"data_show_map":true,"goal_meta_link_text":"UN Metadata","graph_title":"","graph_type":"line","indicator_number":"3.b.3","indicator_name":"Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis","source_active_1":true,"source_active_2":false,"source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"target_name":"Support the research and development of vaccines and medicines for the communicable and non\u2010communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","target_id":"3.b","title":"Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis","un_custodian_agency":"WHO","un_designated_tier":"3","page_content":"","national_metadata_updated_date":"2021-02-10","goal_number":"3","target_number":"3.b","reporting_status":"notstarted","indicator_sort_order":"03-0b-03"}